comparemela.com
Home
Live Updates
Current Treatment Perspectives for CAR T-Cell Therapy in R/R B-Cell Lymphoma : comparemela.com
Current Treatment Perspectives for CAR T-Cell Therapy in R/R B-Cell Lymphoma
Chimeric antigen receptor T-cell therapy has proven to be an effective adoptive cellular therapy against relapsed/refractory B-cell lymphoma.
Related Keywords
Little Rock ,
Arkansas ,
United States ,
University Of Arkansas ,
Aakash Mukherjee ,
Department Of Internal Medicine ,
College Of Medicine ,
Winthropp Rockefeller Cancer Institute ,
Winthropp Rockefeller Cancer Institute Transplant Center ,
Cancer Institute Transplant Center ,
Cancer Institute ,
Medical Sciences ,
Internal Medicine ,
Contributing Kite ,
Relapsed Refractoryb Cell Lymphoma ,
Patients With Relapsed Refractory Diffuse Largeb Cell Lymphoma ,
Scholar 1 Study ,
Zuma 1 Trial ,
Nct02348216 ,
Axicabtagene Ciloleucel ,
Zuma 7 Trial ,
Nct03391466 ,
Transform Trial ,
Nct03575351 ,
D ,
Winthropp Rockefeller Cancer Institute At The University Of Arkansas For Medical Sciences ,
Uams College Of Medicine ,
comparemela.com © 2020. All Rights Reserved.